Anti-apoptotic therapy with a Tat fusion protein protects against excitotoxic insults in vitro and in vivo

Experimental Neurology

Volumn 210, Issue 2, 2008, Pages 602-607

  Ju, Kevin L ^a   Manley, Nathan C ^a   Sapolsky, Robert M ^a  

^a STANFORD UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL PENETRATING PEPTIDE; FUSION PROTEIN TAT BCL XL; GLUTAMIC ACID; HYBRID PROTEIN; KAINIC ACID; PROTEIN BCL XL; TRANSACTIVATOR PROTEIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; DRUG EFFICACY; EXCITOTOXICITY; HIPPOCAMPUS; MALE; NEUROPROTECTION; NEUROTOXICITY; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN FUNCTION; RAT; SEIZURE; SPRAGUE DAWLEY RAT;

ANIMALS; APOPTOSIS; BCL-X PROTEIN; CELLS, CULTURED; DISEASE MODELS, ANIMAL; DRUG INTERACTIONS; EMBRYO, MAMMALIAN; GENE PRODUCTS, TAT; GLUTAMIC ACID; HIPPOCAMPUS; KAINIC ACID; MALE; NEUROGLIA; NEURONS; NEUROTOXICITY SYNDROMES; RATS; RATS, SPRAGUE-DAWLEY; RECOMBINANT PROTEINS;

EID: 41149155878     PISSN: 00144886     EISSN: 10902430     Source Type: Journal    
DOI: 10.1016/j.expneurol.2007.12.008     Document Type: Article

References (48)

1. Anderson W. Human gene therapy. Nature 392 (1998) 25-30
2. Bonadio J. Tissue engineering via local gene delivery. J. Mol. Med. 78 (2000) 303-311
3. Brooke S., Bliss T., Franklin L., and Sapolsky R. Quantification of neuron survival in monolayer cultures using an enzyme-linked immunosorbent assay approach, rather than by cell counting. Neurosci. Lett. 267 (1999) 21-24
4. Brooke S., Chan R., Howard S., and Sapolsky R. Endocrine modulation of the neurotoxicity of gp120: implications for AIDS-related dementia complex. Proc. Natl. Acad. Sci. U. S. A. 94 (1997) 9457-9462
5. Cantara S., Donnini S., Giachetti A., Thorpe P.E., and Ziche M. Exogenous BH4/Bcl-2 peptide reverts coronary endothelial cell apoptosis induced by oxidative stress. J. Vasc. Res. 41 (2004) 202-207
6. Cao G., Pei W., Ge H., Liang Q., Luo Y., Sharp F., Lu A., Ran R., Graham S., and Chen J. In vivo delivery of a Bcl-xL fusion protein containing the TAT protein transduction domain protects against ischemic brain injury and neuronal apoptosis. J. Neurosci. 22 (2002) 5423-5431
7. Derossi D., Calvet S., Trembleau A., Brunissen A., Chassaing G., and Prochiantz A. Cell internalization of the third helix of the Antennapedia homeodomain is receptor-independent. J. Biol. Chem. 271 (1996) 18188-18193
8. Diem R., Taheri N., Dietz G.P., Kuhnert A., Maier K., Sattler M.B., Gadjanski I., Merkler D., and Bähr M. HIV-Tat-mediated Bcl-XL delivery protects retinal ganglion cells during experimental autoimmune optic neuritis. Neurobiol. Dis. 20 (2005) 218-226
9. Dietz G.P., and Bähr M. Delivery of bioactive molecules into the cell: the Trojan horse approach. Mol. Cell. Neurosci. 27 (2004) 85-131
10. Dietz G.P., Dietz B., and Bähr M. Bcl-x(L) increases axonal numbers but not axonal elongation from rat retinal explants. Brain Res. Bull. 70 (2006) 117-123
11. Dietz G.P., Kilic E., and Bähr M. Inhibition of neuronal apoptosis in vitro and in vivo using TAT-mediated protein transduction. Mol. Cell. Neurosci. 21 (2002) 29-37
12. Dwyer B., Wasterlain C., Fujikawa D., and Yamada L. Brain protein metabolism in epilepsy. Adv. Neurol. 44 (1986) 903-918
13. Ebert S., Dietz G.P., Mitchell T.J., Michel U., Bähr M., and Nau R. Limited protection of TAT-Bcl-X(L) against pneumolysin-induced neuronal cell death. Neurosci. Lett. 384 (2005) 349-353
14. Eck S. The prospects for gene therapy. Hosp. Pract. 34 (1999) 67-75
15. Elliot G., and O'Hare P. Intercellular trafficking and protein delivery by a herpesvirus structural protein. Cell 88 (1997) 223-233
16. Embury J., Klein D., Pileggi A., Ribeiro M., Jayaraman S., Molano R., Fraker C., Kenyon N., Ricordi C., Inverardi L., and Pastori R. Proteins linked to a protein transduction domain efficiently transduce pancreatic islets. Diabetes 50 (2001) 1706-1713
17. Futaki S., Suzuki T., Ohashi W., Yagami T., Tanaka S., Ueda K., and Sugiura Y. Arginine-rich peptides. An abundant source of membrane-permeable peptides having potential as carriers for intracellular protein delivery. J. Biol. Chem. 276 (2001) 5836-5840
18. Gonzalez-Garcia M., Garcia I., Ding L., O'Shea S., Boise L., Thompson C., and Nunez G. Bcl-x is expressed in embryonic and postnatal neural tissues and functions to prevent neuronal cell death. Proc. Natl. Acad. Sci. U. S. A. 92 (1995) 4304-4308
19. Hotchkiss R.S., McConnell K.W., Bullok K., Davis C.G., Chang K.C., Schwulst S.J., Dunne J.C., Dietz G.P., Bähr M., McDunn J.E., Karl I.E., Wagner T.H., Cobb J.P., Coopersmith C.M., and Piwnica-Worms D. TAT-BH4 and TAT-Bcl-xL peptides protect against sepsis-induced lymphocyte apoptosis in vivo. J. Immunol. 176 (2006) 5471-5477
20. Hu Y., Benedict M., Wu D., Inohara N., and Nunez G. Bcl-XL interacts with Apaf-1 and inhibits Apaf-1-dependent caspase-9 activation. Proc. Natl. Acad. Sci. U. S. A. 95 (1998) 4386-4391
21. Joliot A., and Prochiantz A. Transduction peptides: from technology to physiology. Nat. Cell. Biol. 6 (2004) 189-196
22. Kharbanda S., Pandey P., Schofield L., Israels S., Roncinske R., Yoshida K., Bharti A., Yuan Z., Saxena S., Weichselbaum R., Nalin C., and Kufe D. Role for Bcl-xL as an inhibitor of cytosolic cytochrome C accumulation in DNA damage-induced apoptosis. Proc. Natl. Acad. Sci. U. S. A. 94 (1997) 6939-6942
23. Kilic E., Dietz G.P., Hermann D.M., and Bähr M. Intravenous TAT-Bcl-Xl is protective after middle cerebral artery occlusion in mice. Ann. Neurol. 52 (2002) 617-622
24. Klein D., Ribeiro M.M., Mendoza V., Jayaraman S., Kenyon N.S., Pileggi A., Molano R.D., Inverardi L., Ricordi C., and Pastori R.L. Delivery of Bcl-XL or its BH4 domain by protein transduction inhibits apoptosis in human islets. Biochem. Biophys. Res. Commun. 323 (2004) 473-478
25. Kluck R.M., Bossy-Wetzel E., Green D.R., and Newmeyer D.D. The release of cytochrome c from mitochondria: a primary site for Bcl-2 regulation of apoptosis. Science 275 (1997) 1132-1136
26. Lai Y., Du L., Dunsmore K.E., Jenkins L.W., Wong H.R., and Clark R.S. Selectively increasing inducible heat shock protein 70 via TAT-protein transduction protects neurons from nitrosative stress and excitotoxicity. J. Neurochem. 94 (2005) 360-366
27. McLaughlin J., Roozendaal B., Dumas T., Gupta A., Ajilore O., Hsieh J., Ho D., Lawrence M., McGaugh J.L., and Sapolsky R. Sparing of neuronal function postseizure with gene therapy. PNAS 97 (2000) 12804-12809
28. Motoyama N., Wang F., Roth K.A., Sawa H., Nakayama K., Nakayama K., Negishi I., Senju S., Zhang Q., and Fujii S. Massive cell death of immature hematopoietic cells and neurons in Bcl-x-deficient mice. Science 267 (1995) 1506-1510
29. Oehmig A., Fraefel C., Breakefield X.O., and Ackermann M. Herpes simplex virus type 1 amplicons and their hybrid virus partners, EBV, AAV, and retrovirus. Curr. Gene Ther. 4 (2004) 385-408
30. Ono M., Sawa Y., Ryugo M., Alechine A.N., Shimizu S., Sugioka R., Tsujimoto Y., and Matsuda H. BH4 peptide derivative from Bcl-xL attenuates ischemia/reperfusion injury thorough anti-apoptotic mechanism in rat hearts. Eur. J. Cardio-thorac. Surg. 27 (2005) 117-121
31. Pan G., O'Rourke K., and Dixit V.M. Caspase-9, Bcl-XL, and Apaf-1 form a ternary complex. J. Biol. Chem. 273 (1998) 5841-5845
32. Parsadanian A.S., Cheng Y., Keller-Peck C.R., Holtzman D.M., and Snider W.D. Bcl-xL is an antiapoptotic regulator for postnatal CNS neurons. J. Neurosci. 18 (1998) 1009-1019
33. Phillips R.G., Monje M.L., Giuli L.C., Meier T.J., Yenari M.A., Kunis D., and Sapolsky R.M. Gene therapy effectiveness differs for neuronal survival and behavioral performance. Gene Therapy 8 (2001) 579-585
34. Pizzi M., Sarnico I., Boroni F., Benarese M., Steimberg N., Mazzoleni G., Dietz G.P., Bähr M., Liou H.C., and Spano P.F. NF-kappaB factor c-Rel mediates neuroprotection elicited by mGlu5 receptor agonists against amyloid beta-peptide toxicity. Cell Death Differ. 12 (2005) 761-772
35. Prochiantz A. Messenger proteins: homeoproteins, TAT and others. Curr. Opin. Cell. Biol. 12 (2000) 400-406
36. Sapolsky R.M. Neuroprotective gene therapy against acute neurological insults. Nat. Rev. Neurosci. 4 (2003) 61-69
37. Sastry P.S., and Rao K.S. Apoptosis and the nervous system. J. Neurochem. 74 (2000) 1-20
38. Schwarze S.R., Ho A., Vocero-Akbani A., and Dowdy S.F. In vivo protein transduction: delivery of a biologically active protein into the mouse. Science 285 (1999) 1569-1572
39. Shimizu S., Konishi A., Kodama T., and Tsujimoto Y. BH4 domain of antiapoptotic Bcl-2 family members closes voltage-dependent anion channel and inhibits apoptotic mitochondrial changes and cell death. Proc. Natl. Acad. Sci. U. S. A. 97 (2000) 3100-3105
40. Susin S.A., Lorenzo H.K., Zamzami N., Marzo I., Snow B.E., Brothers G.M., Mangion J., Jacotot E., Costantini P., Loeffler M., Larochette N., Goodlett D.R., Aebersold R., Siderovski D.P., Penninger J.M., and Kroemer G. Molecular characterization of mitochondrial apoptosis-inducing factor. Nature 397 (1999) 441-446
41. Tsujimoto Y., and Shimizu S. Bcl-2 family: life-or-death switch. FEBS Lett. 466 (2000) 6-10
42. Tung C.H., Mueller S., and Weissleder R. Novel branching membrane translocational peptide as gene delivery vector. Bioorg. Med. Chem. 10 (2002) 3609-3614
43. Verma I.M., and Weitzman M.D. Gene therapy: twenty-first century medicine. Annu. Rev. Biochem. 74 (2005) 711-738
44. Vives E., Brodin P., and Lebleu B. A truncated HIV-1 Tat protein basic domain rapidly translocates through the plasma membrane and accumulates in the cell nucleus. J. Biol. Chem. 272 (1997) 16010-16017
45. Weise J., Isenmann S., Klocker N., Kugler S., Hirsch S., Gravel C., and Bähr M. Adenovirus-mediated expression of ciliary neurotrophic factor (CNTF) rescues axotomized rat retinal ganglion cells but does not support axonal regeneration in vivo. Neurobiol. Dis. 7 (2000) 212-223
46. Yang J., Liu X., Bhalla K., Kim C.N., Ibrado A.M., Cai J., Peng T.I., Jones D.P., and Wang X. Prevention of apoptosis by Bcl-2: release of cytochrome c from mitochondria blocked. Science 275 (1997) 1129-1132
47. Yin W., Cao G., Johnnides M.J., Signore A.P., Luo Y., Hickey R.W., and Chen J. TAT-mediated delivery of Bcl-xL protein is neuroprotective against neonatal hypoxic-ischemic brain injury via inhibition of caspases and AIF. Neurobiol. Dis. 21 (2006) 358-371
48. Zhao M., and Weissleder R. Intracellular cargo delivery using tat peptide and derivatives. Med. Res. Rev. 24 (2004) 1-12